Lipid vesicle encapsulation is an
efficient approach to transfer
quantum dots (QDs) into aqueous solutions, which is important for
renewable energy applications and biological imaging. However, little
is known about the molecular organization at the interface between
a QD and lipid membrane. To address this issue, we investigated the
properties of 3.0 nm CdSe QDs encapsulated within phospholipid membranes
displaying a range of phase transition temperatures (Tm). Theoretical and experimental results indicate that
the QD locally alters membrane structure, and in turn, the physical
state (phase) of the membrane controls the optical and chemical properties
of the QDs. Using photoluminescence, ICP-MS, optical microscopy, and
ligand exchange studies, we found that the Tm of the membrane controls optical and chemical properties
of lipid vesicle-embedded QDs. Importantly, QDs encapsulated within
gel-phase membranes were ultrastable, providing the most photostable
non-core/shell QDs in aqueous solution reported to date. Atomistic
molecular dynamics simulations support these observations and indicate
that membranes are locally disordered displaying greater disordered
organization near the particle–solution interface. Using this
asymmetry in membrane organization near the particle, we identify
a new approach for site-selective modification of QDs by specifically
functionalizing the QD surface facing the outer lipid leaflet to generate
gold nanoparticle–QD assemblies programmed by Watson–Crick
base-pairing.
Living cells contain a range of densely phosphorylated surfaces, including phospholipid membranes, ribonucleoproteins, and nucleic acid polymers. Hyperphosphorylated surfaces also accumulate in neurodegenerative diseases as neurofibrillar tangles. We have synthesized and structurally characterized a precisely patterned phosphotyrosine surface and establish this assembly as a surrogate of the neuronal tangles by demonstrating its high-affinity binding to histone H1. This association with nucleic acid binding proteins underscores the role such hyperphosphorylated surfaces may play in disease and opens functional exploration into protein-phosphorylated surface interactions in a wide range of other complex assemblies.
The dynamics of the gel to fluid phase transformation in 100 nm large unilamellar vesicles (LUV) of 1,2-dipalmitoyl(d62)-sn-glycero-3-phosphocholine (d62-DPPC), has been studied by laser-induced temperature-jump initiation coupled with time-resolved infrared spectroscopy and by MD simulations. The infrared transients that characterize the temperature dependent phase transformation are complex, extending from the nanosecond to the millisecond time scales. An initial fast (submicrosecond) component can be modeled by partial melting of the gel domains, initiated at pre-existing defects at the edges of the faceted structure of the gel phase. Molecular dynamics simulations support the model of fast melting from edge defects. The extent of melting during the fast phase is limited by the area expansion on melting, which leads to a surface pressure that raises the effective melting temperature. Subsequent melting is observed to follow highly stretched exponential kinetics, consistent with collective relaxation of the surface pressure through a hierarchy of surface undulations with different relaxation times. The slowest step is water diffusion through the bilayer to allow the vesicle volume to grow along with its expanded surface area. The results demonstrate that the dominant relaxation in the gel to fluid phase transformation in response to a large T-jump perturbation (compared to the transition width) is fast (submicrosecond), which has important practical and fundamental consequences.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.